| Index | S&P 500 | P/E | 51.47 | EPS (ttm) | 6.08 | Insider Own | 2.24% | Shs Outstand | 161.91M | Perf Week | -3.12% |
| Market Cap | 50.67B | Forward P/E | 30.45 | EPS next Y | 10.28 | Insider Trans | -1.73% | Shs Float | 148.27M | Perf Month | 11.01% |
| Enterprise Value | 43.57B | PEG | 4.31 | EPS next Q | 2.33 | Short Float | 2.84% | Perf Quarter | 51.74% | ||
| Income | 1.01B | P/S | 14.65 | EPS this Y | 16.32% | Short Ratio | 2.48 | Perf Half Y | 82.38% | ||
| Sales | 3.46B | P/B | 6.82 | EPS next Y | 11.27% | ROA | 11.20% | Short Interest | 4.20M | Perf YTD | 40.20% |
| Book/sh | 45.90 | P/C | 7.00 | EPS next 5Y | 11.93% | ROE | 14.00% | 52W High | 325.99 -4.00% | Perf Year | 9.17% |
| Cash/sh | 44.73 | P/FCF | 30.86 | EPS past 3/5Y | 21.94% 18.18% | ROIC | 10.38% | 52W Low | 148.05 111.39% | Perf 3Y | 60.67% |
| Dividend Est. | — | EV/EBITDA | 33.62 | Sales past 3/5Y | 14.03% 16.88% | Gross Margin | 74.96% | Volatility | 2.61% 3.07% | Perf 5Y | -2.37% |
| Dividend TTM | — | EV/Sales | 12.60 | EPS Y/Y TTM | 25.10% | Oper. Margin | 29.93% | ATR (14) | 9.24 | Perf 10Y | 700.41% |
| Dividend Ex-Date | — | Quick Ratio | 5.46 | Sales Y/Y TTM | 16.51% | Profit Margin | 29.34% | RSI (14) | 60.93 | Recom | 2.35 |
| Dividend Gr. 3/5Y | — | Current Ratio | 5.46 | EPS Q/Q | 18.09% | SMA20 | 2.22% | Beta | 0.87 | Target Price | 300.50 |
| Payout | 0.00% | Debt/Eq | 0.02 | Sales Q/Q | 17.62% | SMA50 | 10.25% | Rel Volume | 0.82 | Prev Close | 310.34 |
| Employees | 7,928 | LT Debt/Eq | 0.02 | Earnings | Nov 25 | SMA200 | 49.58% | Avg Volume | 1.68M | Price | 312.96 |
| IPO Date | Oct 16, 2013 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 5.49% 2.49% | Net Debt/EBITDA | -5.48 | Volume | 1,373,533 | Change | 0.84% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Oct-29-26 | Reiterated | Mizuho Securities | Outperform | $280 → $345 |
| Oct-28-26 | Reiterated | Barclays | Overweight | $360 → $375 |
| Oct-26-26 | Reiterated | Robert W. Baird | $300 → $350 | |
| Oct-19-26 | Reiterated | Barclays | Overweight | $315 → $360 |
| Oct-15-26 | Reiterated | Oppenheimer | Outperform | $300 → $325 |
| Sep-08-26 | Reiterated | Wells Fargo | Overweight | $320 → $330 |
| Aug-27-26 | Reiterated | Raymond James | Outperform | $225 → $330 |
| Aug-27-26 | Reiterated | UBS | Neutral | $275 → $325 |
| Aug-27-26 | Reiterated | Stifel Nicolaus | Buy | $275 → $300 |
| Aug-27-26 | Reiterated | Robert W. Baird | $260 → $300 |
Veeva Systems Inc. is a leading provider of cloud-based software solutions, exclusively dedicated to the global life sciences industry. Its extensive operational presence spans across North America, Europe, the Asia Pacific region, the Middle East, Africa, and Latin America. The company's product portfolio is primarily structured around two major offerings. First, the Veeva Commercial Cloud delivers an integrated suite of software, data, and analytics tools designed to optimize commercial operations. This includes vital applications such as Veeva Customer Relationship Management (CRM) and its specialized Medical CRM, Veeva Closed Loop Marketing (CLM), sophisticated analytics via Veeva CRM MyInsights, approved email communication with Veeva CRM Approved Email, digital engagement tools like Veeva CRM Engage, commercial alignment through Veeva Align, event management capabilities with Veeva CRM Events Management, data warehousing solutions (Veeva Nitro), data services (Veeva OpenData, Veeva Link), master data management (Veeva Network), advanced analytical insights (Veeva Crossix, Veeva Data Cloud), and patient engagement platforms (MyVeeva for Patients). Secondly, Veeva Vault provides a robust collection of cloud-native enterprise content and data management applications. These applications are engineered to support both critical commercial functions—encompassing sales, marketing, and medical content and communications—and comprehensive research and development processes, including clinical trials, regulatory compliance, quality management, and patient safety. Beyond its software, Veeva offers a wide array of professional and support services. These range from strategic implementation and deployment planning, project management, and detailed requirements analysis to solution design and configuration. They also include system environment management and deployment, expert consulting for business process transformation related to Veeva solutions, technical guidance on data migration and systems integrations, comprehensive training programs, and ongoing managed services such as outsourced systems administration. Tracing its origins, the company was incorporated in 2007 as Verticals onDemand, Inc., and subsequently rebranded to Veeva Systems Inc. in April 2009. Its corporate headquarters are situated in Pleasanton, California.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2026 1/31/2026 | FY 2025 1/31/2025 | FY 2024 1/31/2024 | FY 2023 1/31/2023 | FY 2022 1/31/2022 | FY 2021 1/31/2021 | FY 2020 1/31/2020 | FY 2019 1/31/2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 3,458 | 3,195 | 2,747 | 2,364 | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 865 | 782 | 700 | 677 | — | — | — | — | — | |
| Gross Profit | 2,592 | 2,413 | 2,047 | 1,686 | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 736 | 730 | 662 | 628 | — | — | — | — | — | |
| Research and Development | 822 | 767 | 693 | 629 | — | — | — | — | — | |
| Other Operating Expense | 0 | 0 | 1 | 0 | — | — | — | — | — | |
| Operating Income | 1,035 | 916 | 691 | 429 | — | — | — | — | — | |
| Interest Expense | 0 | 0 | 0 | 0 | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 293 | 278 | 228 | 159 | — | — | — | — | — | |
| Net Income Before Taxes | 1,329 | 1,195 | 919 | 588 | — | — | — | — | — | |
| Income Taxes | 313 | 286 | 205 | 62 | — | — | — | — | — | |
| Consolidated Net Income | 1,014 | 909 | 714 | 526 | — | — | — | — | — | |
| Net Income From Continuing Operations | 1,014 | 909 | 714 | 526 | — | — | — | — | — | |
| Net Income | 1,014 | 909 | 714 | 526 | — | — | — | — | — | |
| EPS (Recurring) | 6.21 | 5.55 | 4.41 | 3.27 | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 6.21 | 5.55 | 4.41 | 3.27 | — | — | — | — | — | |
| EPS (Diluted) | 6.08 | 5.44 | 4.32 | 3.22 | — | — | — | — | — | |
| EBITDA | 1,296 | 1,245 | 959 | 625 | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 51.47 | 37.49 | 54.00 | 64.41 | — | — | — | — | — | |
| Price To Sales Ratio | 14.66 | 10.47 | 13.76 | 14.13 | — | — | — | — | — | |
| Gross Margin | 74.96 | 75.52 | 74.52 | 71.32 | — | — | — | — | — | |
| Operating Margin | 29.93 | 28.67 | 25.15 | 18.15 | — | — | — | — | — | |
| Net Margin | 29.32 | 28.45 | 25.99 | 22.25 | — | — | — | — | — | |
| Shares Outstanding | 162 | 164 | 162 | 161 | — | — | — | — | — | |
| Market Capitalization | 50,700 | 33,443 | 37,788 | 33,393 | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Faddis Jonathan | SVP, Gen. Counsel, Secretary | Oct 14 '26 | Sale | 299.72 | 5,198 | 1,557,920 | 4,130 | Oct 16 |
| Rizzo Daniel J | EVP, Sales, Consulting, & Svcs | Oct 02 '26 | Sale | 276.51 | 4,841 | 1,338,578 | 7,665 | Oct 05 |
| Kondath Vipin | Chief Accounting Officer | Oct 01 '26 | Option Exercise | 0.00 | 168 | 0 | 2,951 | Oct 05 |
| Faddis Jonathan | SVP, Gen. Counsel, Secretary | Oct 01 '26 | Option Exercise | 0.00 | 1,636 | 0 | 10,964 | Oct 05 |
| Zuppas Eleni Nitsa | President & Chief of Staff | Oct 01 '26 | Option Exercise | 0.00 | 2,181 | 0 | 35,599 | Oct 05 |
| Van Wagener Brian | Chief Financial Officer | Oct 01 '26 | Option Exercise | 0.00 | 1,636 | 0 | 10,961 | Oct 05 |
| Schwenger Thomas D. | Pres. & Chief Customer Officer | Oct 01 '26 | Option Exercise | 0.00 | 2,907 | 0 | 21,356 | Oct 05 |
| Rizzo Daniel J | EVP, Sales, Consulting, & Svcs | Oct 01 '26 | Option Exercise | 0.00 | 1,672 | 0 | 13,360 | Oct 05 |
| Schwenger Thomas D. | Pres. & Chief Customer Officer | Sep 14 '26 | Sale | 265.20 | 1,000 | 265,200 | 18,449 | Sep 16 |
| Hung Priscilla | Director | Sep 09 '26 | Sale | 261.04 | 750 | 195,780 | 3,242 | Sep 11 |
| Wallach Matthew J | Director | Sep 01 '26 | Option Exercise | 0.00 | 460 | 0 | 107,393 | Sep 03 |
| SEKHRI PAUL J | Director | Sep 01 '26 | Option Exercise | 0.00 | 460 | 0 | 15,651 | Sep 03 |
| Ritter Gordon | Director | Sep 01 '26 | Option Exercise | 0.00 | 541 | 0 | 1,136 | Sep 03 |
| MOHR MARSHALL | Director | Sep 01 '26 | Option Exercise | 0.00 | 525 | 0 | 6,501 | Sep 03 |
| Hung Priscilla | Director | Sep 01 '26 | Option Exercise | 0.00 | 477 | 0 | 3,992 | Sep 03 |